Two engineering research centers run by businesses that have settled in the Taizhou Medical High-tech Zone were recently upgraded to provincial-level engineering research centers.
An animal test conducted by Jiangsu Meifengli Medical Technology assisted in the development of a transcatheter aortic valve system to be approved for marketing.
A pet drug efficacy test and a field trial for the evaluation of pet drugs conducted by Taizhou Bioally Technology Co Ltd recently got the green light.
A new infliximab or intravenously injected drug produced by Taizhou Mabtech Pharmaceutical Co recently got the green light to be sold on the Peruvian market.